Latham & Watkins represented PROCEPT in the transaction.PROCEPT BioRobotics Corporation, a commercial-stage surgical robotics company focused on advancing patient care by developing transformative solutions in urology, announced…
Procept BioRobotics’ $163.9 Million Initial Public Offering

























